FindMyKOL
Clinical trialNCT07053917RecruitingPhase 1Interventional

Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability

SponsorJohns Hopkins UniversityEnrollment20Chronic StrokeHemiparesis After StrokeHemiplegia Following Ischemic StrokeHemiplegia and HemiparesisHemiplegia and/or Hemiparesis Following StrokeIntracerebral Haemorrhage+6 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The main purpose of the current studies is to evaluate the safety and tolerability of psilocybin in patients with chronic stroke.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Johns Hopkins

    Baltimore, Maryland, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Psilocybin
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
9 Feb 2026
Primary completion
28 Feb 2027
Completion
31 Mar 2027
Last update posted
13 Feb 2026
Registered enrollment
20
Registry id
NCT07053917
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.